Apomorphine Sublingual Film for OFF episodes in PD: Impact on Orthostatic Hypotension during Dose-Optimization

被引：0
|
作者：
Jost, W. [1 ]
Coelho, M. [2 ]
Fonseca, M. [3 ]
Castilla-Fernandez, G. [3 ]
Magalhaes, D. [3 ]
Muhr, C. Denecke [3 ]
机构：
[1] Parkinson Klin Ortenau, Wolfach, Germany
[2] Hosp Santa Maria, Inst Med Mol, Neurol Clin Res Unit, Lisbon, Portugal
[3] BIAL Portela & Ca SA, Porto, Portugal
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2023年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO-463
引用
收藏
页码：616 / 616
页数：1
相关论文
共 50 条
  • [31] Motor Responses to Apomorphine Sublingual Film Compared With Levodopa in Patients With Parkinson's Disease and "OFF" Episodes
    Hui, Jennifer
    Fox, Susan
    Neeson, William
    Sciarappa, Kenneth
    Pappert, Eric
    Navia, Bradford
    [J]. NEUROLOGY, 2021, 96 (15)
  • [32] A Thorough QT Study of Apomorphine Sublingual Film in Patients With Parkinson's Disease Complicated By "OFF" Episodes
    Stocchi, F.
    Wilks, K. L.
    Peckham, E. L.
    De Pandis, M. F.
    Sciarappa, K.
    Agbo, A.
    Kleiman, R.
    Blum, D.
    Navia, B.
    [J]. MOVEMENT DISORDERS, 2019, 34 : S12 - S12
  • [33] Apomorphine Sublingual Film Compared with Subcutaneous Apomorphine for OFF Episodes in Parkinson's Disease: An Open-Label, Randomized, Crossover Study
    Stocchi, Fabrizio
    Rascol, Olivier
    Poewe, Werner
    Chaudhuri, K. Ray
    Kassubek, Jan
    Lopez Manzanares, Lydia
    Zhang, Yi
    Bowling, Alyssa
    Pappert, Eric
    Wu, Stacy
    [J]. JOURNAL OF PARKINSONS DISEASE, 2023, 13 (08) : 1329 - 1342
  • [34] Apomorphine sublingual film versus subcutaneous apomorphine in the treatment of OFF episodes in Parkinson's disease: results from an assessment of patient satisfaction
    Schwarz, J.
    Carroll, C.
    Ebersbach, G.
    Kulisevsky, J.
    Tessitore, A.
    Zhang, I.
    Bowling, A.
    Wu, S.
    Pappert, E.
    Thach, A.
    [J]. MOVEMENT DISORDERS, 2022, 37 : S352 - S352
  • [35] Indirect Comparison of Apomorphine Sublingual Film Versus Levodopa Inhalation Powder for "OFF" Episodes in Parkinson's Disease
    Thach, A.
    Zichlin, M.
    Kirson, N.
    Yang, K.
    Gaburo, K.
    Pappert, E.
    Mehta, D.
    Williams, G.
    [J]. MOVEMENT DISORDERS, 2021, 36 : S197 - S197
  • [36] Long-term Safety and Tolerability of Apomorphine Sublingual Film in Patients with Parkinson's Disease and "OFF" Episodes
    Ondo, William
    Ellenbogen, Aaron L.
    Isaacson, Stuart
    Espay, Alberto J.
    Bhargava, Parul
    Worden, MaryAlice
    Blum, David
    Navia, Bradford
    [J]. NEUROTHERAPEUTICS, 2019, 16 (03) : 913 - 913
  • [37] Apomorphine Sublingual Film for OFF Episodes in Parkinson's Disease: Incremental Motor Improvement Observed with Increasing Doses
    Isaacson, S.
    Zhang, I.
    Pappert, E.
    Bowling, A.
    [J]. MOVEMENT DISORDERS, 2022, 37 : S334 - S335
  • [38] APOMORPHINE SUBLINGUAL FILM DOES NOT WORSEN DYSKINESIA IN THE LONG-TERM TREATMENT OF "OFF" EPISODES IN PARKINSON'S DISEASE
    Klos, K. J.
    Hui, J. S.
    Zhang, I.
    Navia, B.
    Pappert, E.
    [J]. PARKINSONISM & RELATED DISORDERS, 2023, 113 : 42 - 42
  • [39] Cost-Effectiveness of Apomorphine Sublingual Film as an "On-Demand" Treatment for "OFF" Episodes in Patients with Parkinson's Disease
    Thach, Andrew
    Kirson, Noam
    Zichlin, Miriam L.
    Dieye, Ibrahima
    Pappert, Eric
    Williams, G. Rhys
    [J]. JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCH, 2021, 8 (02): : 110 - +
  • [40] Efficacy, Safety, and Tolerability of Supratherapeutic Doses of Apomorphine Sublingual Film for the Treatment of "OFF" Episodes in Patients With Parkinson's Disease
    Olanow, C.
    Stocchi, F.
    Wilks, K.
    Peckham, E.
    De Pandis, M.
    Sciarappa, K.
    Kleiman, R.
    Blum, D.
    Navia, B.
    [J]. MOVEMENT DISORDERS, 2019, 34
12345